Home » Topics » BioWorld Science

BioWorld Science
RSS

ONTC-534 shows promising activity in prostate cancer models

Oct. 20, 2021

HPK1 inhibitor RGT-197 potentiates antitumor immunity

Oct. 20, 2021

Drosophila model reveals damaging effect of tumors on blood-brain barrier permeability

Oct. 20, 2021

Calpain inhibitor BLD-2736 is protective against spinocerebellar ataxia type 3

Oct. 20, 2021

Targeting integrated epigenetic/metabolic pathways lowers EZHIP in a subset of PFA ependymomas

Oct. 20, 2021

BrainStorm presents preclinical data on MSC-NTF exosomes in models of acute lung injury

Oct. 19, 2021

Boehringer Ingelheim exercises IP options to support development of gene therapy for cystic fibrosis

Oct. 19, 2021

Enesi and NIAID enter agreement to study ImplaVax-enabled pandemic flu vaccine

Oct. 19, 2021

NCI awards SBIR grant to Orphagen to develop OR-449 for adrenocortical carcinoma

Oct. 19, 2021

Nordic Nanovector and University of Pennsylvania establish CD37-targeting CAR-T cell collaboration

Oct. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...